title: Drug approvals: '08 in review. Olopatadine hydrochloride (Patanase) nasal spray.
authors.affiliation: Oregon Health and Science University, Portland, Ore., USA.
authors.forename: Gary
authors.initials: G
authors.lastname: Laustsen
authors.forename: Fernando
authors.initials: F
authors.lastname: Carrillo
authors.forename: Jessica
authors.initials: J
authors.lastname: Johnson
authors.forename: Cynthia
authors.initials: C
authors.lastname: Smith
mesh_terms: D000280:Administration, Inhalation; D018926:Anti-Allergic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003990:Dibenzoxepins / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000069605:Olopatadine Hydrochloride; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D003990:Dibenzoxepins; D000069605:Olopatadine Hydrochloride